Andrew Xian Chen
Founder at Cali Biosciences Co. Ltd.
Profile
Andrew Xian Chen is the founder of SD Pharmaceuticals, Inc. (founded in 2004), Encore Therapeutics, Inc. (founded in 2006), LATITUDE Pharmaceuticals, Inc. (founded in 2003), and Cali Biosciences Co. Ltd.
(founded in 2021), where he holds the title of Executive Director & Chief Scientific Officer.
He is currently the Chief Executive Officer & Director at Cali Biosciences Us LLC and a Director at Cali Shenzhen Biosciences Co. Ltd.
Dr. Chen received a doctorate degree from the College of Pharmacy & Health Sciences in 1992, a graduate degree from the same institution in 1988, and an undergraduate degree from Zhejiang University School of Medicine in 1983.
Andrew Xian Chen active positions
| Companies | Position | Start |
|---|---|---|
Cali Biosciences Co. Ltd.
 Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Founder | 17/03/2021 |
| Cali Biosciences Us LLC | Chief Executive Officer | - |
| Cali Shenzhen Biosciences Co. Ltd. | Director/Board Member | - |
Former positions of Andrew Xian Chen
| Companies | Position | End |
|---|---|---|
SD Pharmaceuticals, Inc.
 SD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Savara, Inc., SD Pharmaceuticals, Inc. is a company that researches and develops reformulated treatment products for cancer and other infectious diseases. The company is based in Carlsbad, CA. The company was founded by Andrew Xian Chen. SD Pharmaceuticals was acquired by Mast Therapeutics, Inc. on April 28, 2006 for $9.89 million. | Founder | - |
| Encore Therapeutics, Inc. | Founder | - |
LATITUDE Pharmaceuticals, Inc.
 LATITUDE Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services LATITUDE Pharmaceuticals, Inc. provides generic drug formulation services. The private company is based in San Diego, CA. The company was founded by Andrew Xian Chen. | Founder | - |
Training of Andrew Xian Chen
| Zhejiang University School of Medicine | Undergraduate Degree |
| College of Pharmacy & Health Sciences | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
SD Pharmaceuticals, Inc.
SD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Savara, Inc., SD Pharmaceuticals, Inc. is a company that researches and develops reformulated treatment products for cancer and other infectious diseases. The company is based in Carlsbad, CA. The company was founded by Andrew Xian Chen. SD Pharmaceuticals was acquired by Mast Therapeutics, Inc. on April 28, 2006 for $9.89 million. | Health Technology |
| Encore Therapeutics, Inc. | |
Cali Biosciences Co. Ltd.
Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Health Technology |
| Cali Shenzhen Biosciences Co. Ltd. | |
| Cali Biosciences Us LLC | |
LATITUDE Pharmaceuticals, Inc.
LATITUDE Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services LATITUDE Pharmaceuticals, Inc. provides generic drug formulation services. The private company is based in San Diego, CA. The company was founded by Andrew Xian Chen. | Commercial Services |
- Stock Market
- Insiders
- Andrew Xian Chen
